26
Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Embed Size (px)

Citation preview

Page 1: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Benign

Epithelial

Mesenchymal

Malignant

Epithelial

Mesenchymal

Lymphoma

Carcinoid

Page 2: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Tumors of the Stomach Tumors arising from the mucosa

predominate over mesenchymal tumors. These are classified into polyps and

carcinoma. The term “polyp” is applied to any nodule or

mass that projects above the level of surrounding mucosa

The use of the term “polyp” in GI tract is generally restricted to mass lesions arising in the mucosa.

Page 3: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

NEOPLASMS OF THE STOMACH

BenignEpithelial

○ hyperplastic polyps○ Fundic gland polyps○ Adenomatous polyps.

Mesenchymal

MalignantEpithelialMesenchymalLymphomaCarcinoid

Page 4: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Benign Neoplasms of Stomach Mucosal polyps

Epithelial polyps are rare. (0.4%)

Types: 1] hyperplastic polyps; (80% to 85%

2] Fundic gland polyps ( 10%)∼ 3] Adenomatous polyps ( 5%)∼

Appear as sessile or small pedunculated lesions, often multiple that can be removed endoscopically.

All three types arise in patient with chronic gastritis. Large polyps are very rare.

- The risk of carcinoma is moderate in adenomatous polyp, slight in hyperplastic polyp, and nil in fundic gland polyps.

Page 5: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Adenomatous polyp of the stomach. Note the large size of the polyp and its lobulated configuration.A small ulceration ( arrow) can be identified on its surface.

Page 6: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

- Carcinoma – 90-95%- Lymphoma – 4%- Carcinoids – 3%- Malignant spindle cell – 2%

Page 7: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Gastric carcinoma is the second leading cause of cancer-related deaths in the world, with a widely varying geographic incidence.

Page 8: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

1. Gastric adenocarcinoma

Epidemiology• The incidence of gastric carcinoma is five to ten

times higher in Japan than in the United States. It is also high in China and Chile.

Page 9: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

• There are two patterns Intestinal type and Diffuse type

Intestinal type occur on top of ch. Gastritis and intestinal metaplasia and common in high risk population after age 50 with 2:1 male predominance

Diffuse type arise de novo in

younger age group with with female predominance

.

In the United States, the incidence of Intestinal type had declined since 1950

Page 10: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Gastric adenocarcinomaRisk factors for Gastric CarcinomaRisk factors for Gastric Carcinoma

Intestinal type adenocarcinoma Diet

Nitrites Smoked foods Excessive salt Decreased intake of fresh vegetables and fruits

Ch. Gastritis and intestinal metaplasia Infection by H. pylori

Pernicious anemia

Altered anatomy Diffuse Carcinoma

Undefined, E- cadherine (50%), FGFR2 (33%)

Page 11: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Amplification of HER-2/NEU and increased expression of β-catenin are present in 20% to 30% of cases and are absent in diffuse carcinoma

Page 12: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

Gastric Carcinoma Precancerous lesions ( intestinal type)

1. Chronic atrophic gastritis associated

with pernicious anemia.

2. Chronic atrophic gastritis associated

with helicobacter pylori infection.

3. Those with adenomatous and hyperplastic polyps.

4. Following subtotal gastrectomy.

Page 13: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

Gastric carcinoma

Site:

- pylorus and antrum – 50-60%

- cardia – 25%

- body and fundus 15 -25%

lesser curvature 40%

Greater curvature 12%

a favored location is the lesser curvature of the antropyloric region

Page 14: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach Gastric carcinoma

Divided into:

1. Early gastric cancer (lesion limited to mucosa and submucosa)

– appears as a small, flat mucosal thickening that may have a minimal polypoid and ulcerative component.

2. Late gastric cancer

– defined as a gastric carcinoma that has invaded the muscle wall.

It may present in various ways:

- As a fungating mass that protrudes into the lumen.

- As a diffusely infiltrating lesion that causes thickening and contraction of the stomach wall with relatively little mucosal involvement (linitis plastica, or leather-bottle stomach).

- As a malignant ulcer (excavated) with raised, everted edges.

Page 15: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

Page 16: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

Any gastric ulcer that does not heal as expected should be biopsied to rule out carcinoma.

Page 17: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Gastric carcinoma

Intestinal type

Page 18: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

The diffuse variant of gastric carcinoma

Arise de novo from native gastric-type mucous cells that generally do not form glands but rather permeate the mucosa and wall as scattered individual “signet-ring” cells or small clusters in an infiltrative growth pattern.

There is no association with chronic gastritis Poorly differentiated It occurs at early ages with female

predominance.

Risk factors undefinedRare inherited mutation of E-cadherin

leading to autosomal dominant inheritance. Mutations in FGFR2, a member of the fibroblast growth factor

receptor family, and increased expression of metalloproteinases are present in about one-third of cases, but are absent in intestinal-type carcinomas.

Page 19: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Gastric carcinoma

Diffuse variantIntestinal type

Page 20: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach Spread of Gastric carcinoma

Direct: Invades through the muscle wall into the omental

fat. Spread of tumor cells in the peritoneal fluid. Spread to the ovary (Krukenberg’s tumor) and

rectovesical pouch.

Lymphatic metastasis to lymph nodes around the stomach Left supraclavicular node (Virchow’s node) Lymph node metastases are present in about

50% of cases at the time of diagnosis

Blood stream spread to the liver and lung

Page 21: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

Clinical Features of Gastric carcinoma

Early gastric cancer: asymptomatic

Late gastric cancer: Resembling chronic peptic ulcer Anorexia, anemias, weight loss, hematemesis and melena. Tumors near the pylorus may cause gastric outlet obstruction.

Page 22: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

Prognosis of Gastric carcinoma

The prognosis depends on the depth of invasion of the neoplasm.

Early cancer - 85% - 5 years survival

Muscle wall invasion – 30% - 5 years survival

Full thickness invasion and lymph node – 5% - 5 year survival

Histologic features and differentiation are of little prognostic importance.

Page 23: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

2. Malignant lymphoma Two common types occur:

a. Low-grade malignant lymphoma arising in mucosa- associated lymphoid tissue (MALT lymphoma).

b. High-grade aggressive B cell lymphomas, most commonly B immunoblastic lymphoma.

Present as polypoid masses, ulcers, thickened fold.

MALT lymphoma restricted to can be cured by surgical resection ( more likely to be associated with H. pylori)

High grade lymphomas respond to chemotherapy, and

have a 5 year survival rate of about 60%.

Page 24: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

3. Malignant gastric stromal neoplasms Commonest mesenchymal neoplasm (2% of gastric

malignancies) Arise from undifferentiated mesenchymal cells in the

gastric wall with ulceration. Present as large masses that originate in and involve the

wall with ulceration. Composed of spindle cells that show varying cellularity,

pleomorphism and mitotic activity

with smooth muscle or neural

differentiation. Treatment: Surgical resection over 50% survive 5 years.

Page 25: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Malignant neoplasm of stomach

4. Carcinoid tumors

- extremely rare.

- give metastasis in 30% of cases.

Page 26: Benign Epithelial Mesenchymal Malignant Epithelial Mesenchymal Lymphoma Carcinoid

Summary of Gastric Tumors More than 90% of gastric tumors are carcinomas; lymphomas, carcinoids and stromal tumors are relatively

infrequent. The two main types of gastric adenocarcinomas are the

intestinal and diffuse types; macroscopic patterns of both types may be exophytic, flat or depressed, or excavating.

Intestinal type of adenocarcinoma is associated with chronic gastritis caused by H. pylori infection, with gastric atrophy and intestinal metaplasia; composed of malignant cells forming intestinal glands.

Diffuse type of adenocarcinoma is not associated with H. pylori infection; composed of gastric type of mucous cells (signet ring cells) that permeate the mucosa without forming glands.